Login / Signup

Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia.

August CesarecRobert Likić
Published in: Applied health economics and health policy (2017)
The introduction of biosimilar trastuzumab could lead to significant drug cost savings in Croatia.
Keyphrases
  • epidermal growth factor receptor
  • metastatic breast cancer
  • tyrosine kinase
  • combination therapy
  • drug induced
  • replacement therapy